⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CPRX News
Catalyst Pharmaceutical Inc.
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX)
globenewswire.com
CPRX
Catalyst Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalyst Pharmaceuticals, Inc. - CPRX
businesswire.com
CPRX
Are CPRX, TBRG, MDV, ACR Obtaining Fair Deals for their Shareholders?
prnewswire.com
CPRX
ACR
MDV
TBRG
Catalyst Pharmaceuticals Cancels First Quarter 2026 Conference Call and Webcast
globenewswire.com
CPRX
Shareholder Alert: Ademi LLP investigates whether Catalyst Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders
prnewswire.com
CPRX
Form 8-K
sec.gov
CPRX
CPRX Stock Alert: Halper Sadeh LLC is Investigating Whether Catalyst Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
businesswire.com
CPRX
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
globenewswire.com
CPRX
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.
globenewswire.com
CPRX
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
globenewswire.com
CPRX